Articles tagged with Thymus
The thymus teaches the immune system to ignore essential gut bacteria, reducing the risk of inflammatory bowel disease. Researchers found that regulatory T cells come from the thymus and can recognize both self- and non-self-antigens.
Researchers identified a special class of fatty molecules essential for activating immune cells, offering new opportunities for therapeutic interventions. The discovery sheds light on how recognition of these stimulatory fatty molecules by immune cells protects against infection, autoimmune diseases, and cancer.
Researchers at Max Planck Institute successfully generated artificial thymus tissue in mouse embryo, discovering key signalling molecules controlling T cell maturation. The discovery represents a crucial step towards producing artificial thymus glands that could be used to replace or augment damaged organs.
Researchers have developed a personalized immune mouse that can recreate an individual's immune system, allowing for unprecedented analysis of abnormalities contributing to type 1 diabetes and other autoimmune diseases. This model has the potential to develop individualized immunotherapies against cancer and infection.
A new study reveals that tonsils can produce T lymphocytes, a critical type of immune cell, contradicting the long-held belief that they only develop in the thymus. The research found five distinct stages of T-cell development in the tonsil, similar to those in the thymus, but with some differences.
Researchers at Max Planck Institute observe maturation of immune cells in live zebrafish embryos, finding they migrate into and out of thymus multiple times. This process is driven by chemokines alone and is independent of blood circulation.
Primitive lampreys have structures within their gills that play a role similar to the thymus, where T cells develop in mammals and birds. The finding suggests two separate organs for immune cell development preceded the appearance of key features like antibodies and T cell receptors.
Researchers successfully convert thymic epithelial cells into skin multipotent stem cells, exhibiting improved performance in skin regeneration. This discovery may have significant implications for organ transplantation and regeneration, offering new possibilities for treating severe burn victims.
A University of Arizona study found that spaceflight alters gene expression in mice, potentially leading to increased cell death and compromised immune systems. The research suggests that long-duration space missions to destinations like Mars may require new strategies to mitigate these effects.
Researchers have discovered that individuals with a specific HLA B57 gene carry more potent killer T cells, which can recognize and attack HIV-infected cells. This finding may lead to the development of vaccines that provoke a similar response in people without the gene.
Researchers propose a new theory on the cause of autoimmunity in diabetes, suggesting that unusual protein fragments can trigger an immune response. This discovery could lead to a new strategy for preventing type 1 diabetes.
Premature aging of the immune system has been linked to amyotrophic lateral sclerosis (ALS), according to research. Studies found that patients with ALS have reduced CD4+ T cells and thymic malfunction, contributing to disease progression.
Researchers aim to understand mechanisms by which the thymus shuts down, affecting immune system function during aging. The goal is to find ways to turn the organ's function back on to fight disease or aging, potentially leading to longer and healthier lives.
A team of scientists at Children's Hospital of Pittsburgh UPMC has discovered an enzyme crucial for maintaining a robust immune system into old age. The study found that the novel mouse model has a thymus that remains intact throughout its life.
Researchers tracked three children with DiGeorge Syndrome after thymus tissue transplantation to measure the growth of T-cells and assess receptor diversity. The study found that factors regulating T-cell receptor diversity are a thousand times more common than those treating all T-cells alike.
Researchers found that young autoreactive T-cells are more receptive to reeducation into regulatory T-cells. In contrast, older T-cells become fully activated and cause damage. Understanding the developmental stage of T-cells holds promise for developing new therapies for autoimmune diseases.
Researchers at Scripps Florida's Department of Cancer Biology have won multiple grants to study Notch3, ornithine decarboxylase, and vinculin, focusing on immune system regeneration and cancer prevention. This funding supports studies on gene expression, enzyme regulation, and cell-cell adhesion complexes.
Researchers have identified two distinct molecular pathways that control the formation of regulatory T cells (Treg), which are vital in limiting undesirable immune responses. The study shows that if a gene called Carma1 isn't expressed normally, Treg development is impaired in the thymus, but alternative pathways can compensate.
New UGA research sheds light on the important role of the Foxn1 gene in maintaining T cell production in the thymus. The study suggests that understanding how this gene works could lead to new therapies for various illnesses, including age-related immunodeficiency disorders.
A new study has shed light on the inner mechanics of the thymus, revealing its role in negative selection, which prevents immune cells from attacking the body's own tissues. Researchers genetically engineered mice to contain an antigen only in the cortex, finding that T cells programmed to attack it were absent from mature mice.
Researchers at the University of Montreal identified Wnt4 protein as a stimulator of T-cell production, reversing age-related immune system decline. Elevated Wnt4 levels increase T cell progenitors and immature T cells in the thymus, improving immune response to infections.
Researchers at Gladstone and UCSF found that growth hormone therapy stimulates the production of vital T-cells, leading to increased thymic mass and improved immune function. The study suggests that this treatment could help HIV-infected patients rebuild their compromised immune systems.
Researchers found that bone marrow transplant is a successful treatment option for DiGeorge syndrome, with a 75% survival rate. The study also suggests that the thymus may not be necessary for immune development after birth.
Research suggests that ghrelin improves thymic mass and T cell output with increased diversity of the TCR repertoire in mice, highlighting its potential as a therapeutic approach to boost immune function in elderly or immunocompromised individuals.
A cost-effective approach for generating siRNA molecules, called esiRNAs, is described in the article. This method allows scientists to efficiently target virtually any gene in mammalian cells, enabling large-scale studies of gene function.
Recent study results show 75% of babies receiving thymus transplants survive after one year. The procedure has led to survival for most infants who would otherwise die from DiGeorge anomaly. Thymus transplantation is a treatment option that offers new hope to families affected by this rare condition.
Scientists have discovered that autoimmunity can be triggered in the thymus if T cells fail to recognize a single protein as self. This finding suggests that effective strategies to treat autoimmune disease should target not only peripheral sites but also the thymus.
Researchers found that regulatory T cells, which function like immune system police, learn what to protect while in the thymus and that everything they learn may not be good. The cells are diverse and able to recognize endogenous tissue and invaders, but also may not learn to recognize all endogenous tissue.
Researchers at Mayo Clinic discovered that antiretroviral therapy (ART) can dramatically increase the production of disease-fighting T cells in non-HIV-infected individuals, including older adults. This finding has significant implications for developing new cancer vaccines and improving immune protection in vulnerable populations.
Scientists have discovered a way to regrow the thymus, which produces T cells required to fight infection, through inhibiting sex steroids. This breakthrough offers new hope for treating cancer, AIDS, and other immunodeficiencies by improving T cell responses and recovery following bone marrow transplants.
Notch protein plays a crucial role in directing early T-cell development in the thymus, a small organ under the breastbone near the heart. This study provides new insights into the process, shedding light on how Notch signaling contributes to T-cell differentiation and potentially improving outcomes for transplant patients.
Researchers have developed a new tool that allows them to visualize cells in real-time, revealing details about their movement and behavior. The technique, called two-photon laser-scanning microscopy, has provided insights into the goal-oriented migration of activated T cells and the random wanderings of immature T cells.
Researchers used two-photon microscopy to visualize thymocyte migration in intact thymuses. The study found that positively selected T cells follow a clear directional course to the medulla, suggesting long-range signaling cues guide this process.
Researchers found that Omenn syndrome patients have greatly reduced autoimmune regulator (AIRE) expression in their thymuses, which leads to a lack of central tolerance. This results in the survival of autoreactive T cells, causing increased autoimmunity risk.
Researchers from CANVAC, a Canadian network of immunology and virology experts, have developed a new method to assess thymus function using only blood samples. They found that HIV-infected individuals experience decreased thymic function in the first months after infection, leading to lower T-lymphocyte production.
Researchers pinpoint identity of early-stage T-cells in blood, providing tools for studying T-cell development and improving understanding of immune system. The discovery sheds light on thymus-imported cell types and may help uncover why certain T cells are difficult to reconstitute after bone marrow transplants.
Babies with complete DiGeorge syndrome, a fatal genetic disorder, are saved by a new combination of immune suppression and thymus transplantation. The technique reduces the risk of infection and allows infants to develop a functioning immune system.
A new genetic switch has been discovered in the process of T-cell maturation, which is a two-stage process. This finding could lead to ways to produce T-cells in the lab and potentially treat diseases such as AIDS.
Researchers at Duke University Medical Center have successfully treated seven out of 12 children with complete DiGeorge Syndrome using a thymus transplant procedure. The transplants enabled the children's bodies to form new immune systems, leading to improved survival rates and reduced infections.
Researchers found that intracranial gliomas damage the thymus, weakening T cells and preventing a large-scale attack on the tumor. The study suggests that glucocorticoids produced by the adrenal glands contribute to this effect, and highlights the importance of recent thymic emigrant T cells in anti-glioma immunity.
A pilot study found that intrathymic bone marrow injections during heart transplantation reduce acute cellular rejection rates and require fewer anti-rejection drugs, improving patient outcomes. The approach may also lower the risk of chronic rejection.
Researchers have found that thymic cells express hundreds of genes associated with distant organs, foreshadowing self-antigens for T cells. This discovery may lead to a new understanding of immune system mechanisms and the development of autoimmune diseases.
Researchers have discovered a gene, Ian5, that appears to affect the function of the thymus and is linked to the development of type 1 diabetes in rats. The identification of this gene may also contribute to human type 1 diabetes and help researchers understand the underlying mechanisms of the disease.
Researchers at Ohio State University found that a commonly used HIV drug, AZT, does not prevent virus-related damage to the thymus in young cats infected with FIV. The study suggests that antiviral therapy may need to be combined with other treatments to restore thymic function and protect against immune system problems.
Researchers at UC Berkeley found that contract bridge players have increased numbers of immune cells after a game, suggesting a link between brain activity and the immune system. The study suggests that voluntary activities like bridge may help control white blood cell levels to combat disease.
Researchers at Duke University Medical Center have successfully transplanted discarded thymus tissue into two infants with DiGeorge Syndrome, restoring their immune systems and providing long-term treatment. The children's new gland has provided a normally functioning immune system that requires no long-term drug support.
National Jewish researchers identified the specific peptide, ND1, on MHC molecules that controls positive selection of T cells. This discovery helps expand understanding of how the immune system develops and may lead to new treatments for cancer and autoimmune diseases.
Researchers found that the thymus gland remains functional in adults and can produce new T cells after HIV infection is suppressed. After receiving HAART, HIV-infected individuals showed a rapid increase in T-cell production.
Researchers have found that temporarily blocking sex hormones can boost the immune system of people with HIV, cancer, and those who have received immunosuppressive treatments. The study suggests that drugs that suppress sex hormone production may help restore immune function and combat diseases.
Researchers at UT Southwestern Medical Center have found a way to track thymus function and produced new T-cells in patients with HIV. The discovery could lead to therapies that increase T-cell production and aid in recovery from both HIV and cancer treatments.
Researchers have developed a system to mimic the thymus in laboratory settings, enabling the study of HIV's effect on T-cell development. The model has shown that even immature T cells are susceptible to HIV infection, highlighting the need for treatment targeting young individuals.
Researchers at Duke University have made significant advancements in rebuilding the human immune system using thymus transplants. The breakthroughs offer new hope for patients with severe immunodeficiencies and potentially life-threatening illnesses.